Glucagon-like peptide-1 receptor imaging with [Lys40(Ahx-HYNIC- 99mTc/EDDA)NH2]-exendin-4 for the detection of insulinoma. - Wikidata - wikimedia - TriplyDB

Glucagon-like peptide-1 receptor imaging with [Lys40(Ahx-HYNIC- 99mTc/EDDA)NH2]-exendin-4 for the detection of insulinoma.

Glucagon-like peptide-1 receptor imaging with [Lys40(Ahx-HYNIC- 99mTc/EDDA)NH2]-exendin-4 for the detection of insulinoma.

http://www.wikidata.org/entity/Q36662850

about

Advancement in treatment and diagnosis of pancreatic cancer with radiopharmaceuticals Pancreatic insulinomas: Laparoscopic management GLP-1R-targeting magnetic nanoparticles for pancreatic islet imaging.Preclinical evaluation of PAC1 targeting with radiolabeled Maxadilan.99mTc Labeled Glucagon-Like Peptide-1-Analogue (99mTc-GLP1) Scintigraphy in the Management of Patients with Occult Insulinoma.Radioiodinated Exendin-4 Is Superior to the Radiometal-Labelled Glucagon-Like Peptide-1 Receptor Probes Overcoming Their High Kidney Uptake.Selective Arterial Calcium Stimulation With Hepatic Venous Sampling Differentiates Insulinoma From Nesidioblastosis.68Ga-NOTA-Exendin-4 PET/CT in Localization of an Occult Insulinoma and Appearance of Coexisting Esophageal Carcinoma.ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.68Ga-NOTA-exendin-4 PET/CT in detection of occult insulinoma and evaluation of physiological uptake.Glucagon-Like Peptide-1 Receptor PET/CT with 68Ga-NOTA-Exendin-4 for Detecting Localized Insulinoma: A Prospective Cohort Study.Targets and probes for non-invasive imaging of β-cells.Current Status of Radiopharmaceuticals for the Theranostics of Neuroendocrine Neoplasms.Preliminary evaluation of [18F]AlF-NOTA-MAL-Cys39-exendin-4 in insulinoma with PET.Cross sectional and nuclear medicine imaging of pancreatic insulinomas.Fully automated GMP production of [68Ga]Ga-DO3A-VS-Cys40-Exendin-4 for clinical use.Low kidney uptake of GLP-1R-targeting, beta cell-specific PET tracer, 18F-labeled [Nle14,Lys40]exendin-4 analog, shows promise for clinical imaging.Childhood insulinoma masquerading as seizure disorder.

P2860

Q26766690-C2319FF3-8D24-4616-A2DA-0DF6505B4F18 Q26777226-8832F0E6-9750-4754-AF2E-32183498296D Q30588445-0666C718-DC4C-445D-B095-9CC4FD9EE2A3 Q33687453-FC00CC11-CFCE-4B25-839A-86C2E2BCC344 Q36104200-06C8AECB-E5C8-479B-A7EF-94ED22C836CE Q36253935-940A511B-E46A-4D44-8DD2-5DE17A355DD7 Q36433556-B1E948F8-6A54-4860-A980-BEB3DC24A0E7 Q36655954-24F37238-151E-411D-AB25-DCAC8DB2BFD1 Q36849357-27667422-4ACF-4FAE-94CE-DB177CC6024C Q37575739-87355198-E784-40FA-9347-67E723B1917E Q37581371-090CEF77-4468-416D-8FAB-FD283FC49DDE Q37662672-7022F4E5-03C5-418C-B86D-B0F9543BC7A3 Q37731335-D943D2E7-4259-451F-8CCF-E0B7B437D21C Q38901439-5E7EB257-2E9E-432B-A8EC-70D67DD08389 Q38957569-BC17A8B5-1F79-4C52-8D50-E2A3C25A53A3 Q41019277-9BF4DC2F-E7BF-461E-8D2F-E5C09F4D25C6 Q41860402-03D397E7-66BC-402F-8C90-D61F313FF229 Q45999312-90811857-AAB6-4C05-BCA0-65172A2EBAE6

P2860

Glucagon-like peptide-1 receptor imaging with [Lys40(Ahx-HYNIC- 99mTc/EDDA)NH2]-exendin-4 for the detection of insulinoma.

http://www.wikidata.org/entity/Q36662850

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Glucagon-like peptide-1 recept ...... r the detection of insulinoma.

@ast

Glucagon-like peptide-1 recept ...... r the detection of insulinoma.

@en

type

label

Glucagon-like peptide-1 recept ...... r the detection of insulinoma.

@ast

Glucagon-like peptide-1 recept ...... r the detection of insulinoma.

@en

prefLabel

Glucagon-like peptide-1 recept ...... r the detection of insulinoma.

@ast

Glucagon-like peptide-1 recept ...... r the detection of insulinoma.

@en

P1433

Q36662850-2E9334C3-6105-4EBB-B5DD-C6AE82C51E10

P1476

Q36662850-394E2FBB-7E9F-463B-8FE1-238054674D95

P2093

Q36662850-084A194C-B9FF-44EF-ADEB-71C3F0DF013F

Q36662850-0B8591FB-456A-4CB6-B91E-549FAB96FD8B

Q36662850-28197061-6EB7-4616-A373-5748536A2D83

Q36662850-3314D995-BB3F-4CEB-9845-88AE6349E7F5

Q36662850-4CAC199D-88A5-4830-9EF0-BB3DED42437C

Q36662850-50E39B9D-615A-4D0C-B8A6-4AED04BCE19D

Q36662850-5A786ECD-A9A3-4524-AE84-48459F5ACD22

Q36662850-7915DBC5-FD1E-483B-9705-9AE212799BE1

Q36662850-975E2A4F-BFC3-4691-94C1-472DBCFF6432

Q36662850-BC0F7D55-0DE7-4C97-BE87-9A8583069033

P2860

Q36662850-06203F63-80F6-4DF2-B6BA-B03D2A334D14

Q36662850-13927521-C433-4B2A-B9F5-BFA6FE5C6CFF

Q36662850-217C054F-BE95-4BE2-8519-C1E45581E44D

Q36662850-26816997-2BD8-47CA-A974-B6E83B70F3CA

Q36662850-4239F945-6AC1-444C-B40E-0420D6A18AFF

Q36662850-4411DEA7-C1B9-41A6-8FB3-3009A2FFFDED

Q36662850-4F96EB85-3B59-4C1D-9AF8-609906BB8E20

Q36662850-5FD2DD5A-621F-4D0A-A3F4-714F6A1F0423

Q36662850-624BAC84-70B8-403B-9672-CB8F5388D125

Q36662850-66DB9E67-EB15-44A2-AD5F-220B7DF5B22C

P2888

Q36662850-3B46FA10-5258-4ED5-BB4A-DA66CCDFDA94

P304

Q36662850-6E375503-A127-4CE8-B2CF-5CC22A511960

P31

Q36662850-95DCD734-0F57-477C-B716-A5F1FF9EE9D5

P356

Q36662850-A30FAB53-8EEE-4DD2-A47E-F4B2FB9F8C6A

P433

Q36662850-5EFCBD42-3C5E-40C2-A3E1-B6D0DBF89542

P478

Q36662850-09324BCC-FFA4-4E38-A28E-942A705995A8

P50

Q36662850-09BBFC1B-64BD-4A2A-A3D6-7A5AB5183BC5

Q36662850-ABEFCD9E-6E7B-44BD-A0A2-CC9FEF808977

P577

Q36662850-DB9FCE4E-906B-441F-80E3-66DB91609285

P5875

Q36662850-EC0F98E4-1EDC-4FE2-8F85-27425EB89608

P698

Q36662850-DE10CC37-EB90-42AB-B438-A2B49A6225DA

P932

Q36662850-9863A95A-C378-4A87-83DE-1824BFED5998

P356

S00259-012-2299-1

P1433

European Journal of Nuclear Medicine and Molecular Imaging

P1476

Glucagon-like peptide-1 recept ...... or the detection of insulinoma

@en

P2093

Agata Jabrocka-Hybel

http://www.w3.org/2001/XMLSchema#string

Agnieszka Stefańska

http://www.w3.org/2001/XMLSchema#string

Aleksandra Gilis-Januszewska

http://www.w3.org/2001/XMLSchema#string

Alicja Hubalewska-Dydejczyk

http://www.w3.org/2001/XMLSchema#string

Andrzej Matyja

http://www.w3.org/2001/XMLSchema#string

Anna Sowa-Staszczak

http://www.w3.org/2001/XMLSchema#string

Barbara Janota

http://www.w3.org/2001/XMLSchema#string

Czesław Osuch

http://www.w3.org/2001/XMLSchema#string

Dorota Pach

http://www.w3.org/2001/XMLSchema#string

Helmut Mäcke

http://www.w3.org/2001/XMLSchema#string

P2860

The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103

MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates.

68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET.

Endoscopic ultrasonography (EUS) in the localization of insulinoma.

Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting.

PET of insulinoma using ¹⁸F-FBEM-EM3106B, a new GLP-1 analogue

In vitro and in vivo detection of somatostatin receptors in human malignant tissues.

Pancreatic insulinoma: current issues and trends.

Glucagon-like peptide-1 receptor imaging for localization of insulinomas.

Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study.

P2888

s00259-012-2299-1

P304

524-531

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00259-012-2299-1

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P50

Aldona Kowalska

Grzegorz Kamiński

P577

2012-12-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233887333

http://www.w3.org/2001/XMLSchema#string

P698

23224740

http://www.w3.org/2001/XMLSchema#string

P932

3590421

http://www.w3.org/2001/XMLSchema#string